BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Janux Therapeutics, Inc. (JANX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Janux Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
4:24 pm
Sale		 2024-09-30 13G Janux Therapeutics, Inc.
JANX		 BIOTECHNOLOGY VALUE FUND L P 0
0.000%		 -4,579,818decrease
(Position Closed)		 Filing
2024-02-14
09:43 am
Purchase		 2023-12-31 13G Janux Therapeutics, Inc.
JANX		 BIOTECHNOLOGY VALUE FUND L P 4,579,818
9.900%		 472,873increase
(+11.51%)		 Filing
2023-05-30
4:45 pm
Purchase		 2023-05-17 13G Janux Therapeutics, Inc.
JANX		 BIOTECHNOLOGY VALUE FUND L P 4,106,945
9.800%		 4,106,945increase
(New Position)		 Filing